NCT03127982

Brief Summary

The present study aims at evaluating the effects of a CBT intervention, a cultural adaptation of the Unified Protocol for the Trans-diagnostic Treatment of Emotional Disorders (UP) in victims of the Colombian armed conflict. A randomized clinical trial aimed at evaluating the effects of the UP in a group of 100 internally displaced victims of armed conflict living in Bogotá is being implemented. Participants are recruited from several governmental, non-governmental agencies as well as community organizations of victims. Participants are being randomly assigned to treatment condition (N=50) or to waiting-list control (N=50). Treatment consists in 12 biweekly sessions covering the 8 modules of the original UP. The effects of the UP is evaluated through Patient Health Questionnaire (PHQ) and several measures of co-morbid emotional disorders, Anxiety, Depression, PTSD as well as level of functioning and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
109

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

April 7, 2017

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 25, 2017

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2021

Completed
Last Updated

November 18, 2022

Status Verified

November 1, 2022

Enrollment Period

6 years

First QC Date

April 7, 2017

Last Update Submit

November 15, 2022

Conditions

Keywords

Anxiety Depression Emotion PTSD Randomized Clinical Trial

Outcome Measures

Primary Outcomes (2)

  • Changes in diagnostic criteria for depression, anxiety, as assessed by the Patient Health Questionnaire.

    PHQ - complete.

    Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

  • Change in symptoms of post-traumatic stress as measured by the Post-Traumatic Stress Disorder (PTSD)

    Checklist for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) (PCL-5).

    Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

Secondary Outcomes (4)

  • Quality of Life. Self-reported measure assessing the physical health, subjective feelings, leisure activities, social relationships, general activities, satisfaction with medications and life satisfaction.

    Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

  • Anxiety measure.

    Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

  • Depression measure.

    Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

  • Current level of functioning.

    Baseline, and 3-month follow-up.

Study Arms (2)

Group 1

EXPERIMENTAL

Immediately following randomization, participants in this condition attend 12-13 biweekly face-to face individual sessions that last approximately 1.5 hrs each of the cultural adaptation of the Unified Protocol trans diagnostic treatment comprising the following modules: motivation enhancement, psycho-education of emotion, emotion awareness training, cognitive reappraisal, emotion avoidance and emotion-driven behavior, tolerance training for physical sensations, emotion exposure, and relapse prevention. Treatment is provided by graduate students in clinical psychology who have been trained in the UP and receive weekly supervision by experienced clinicians and use a Workbook for homework assigned between sessions.

Behavioral: Unified Protocol

Group 2

ACTIVE COMPARATOR

Participants randomly assigned to this condition do not receive any active intervention during a six-week wait period after randomization, while completing assessment evaluation at the beginning and end of wait list period, after which they receive the same intervention (Unified Protocol) provided to the treatment condition (Group 1).

Behavioral: Unified Protocol

Interventions

The Unified Protocol (UP) is a trans-diagnostic cognitive-behavioral therapy (tCBT) for individuals diagnosed with anxiety disorders, depression and related disorders (which we refer to as emotional disorders).

Also known as: UP for the Transdiagnostic Treatment of Emotional Disorders
Group 1Group 2

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsBased on self-representation.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratorio de Psicología Clínica Uniandes - Universidad de Los Andes

Bogotá, DC, Colombia

Location

Related Publications (1)

  • Castro-Camacho L, Barlow DH, Garcia N, Farchione TJ, Idrobo F, Rattner M, Quant DM, Gonzalez L, Moreno JD. Effects of a Contextual Adaptation of the Unified Protocol in Multiple Emotional Disorders in Individuals Exposed to Armed Conflict in Colombia: A Randomized Clinical Trial. JAMA Psychiatry. 2023 Oct 1;80(10):991-999. doi: 10.1001/jamapsychiatry.2023.2392.

Study Officials

  • Leonidas Castro-Camacho, Ph.D.

    Universidad de Los Andes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The clinical staff participating in the intervention are unaware of the group membership of the subjects; either experimental or wait-list.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Allocation: Randomized Intervention Model: Parallel Assignment Single Blind
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 7, 2017

First Posted

April 25, 2017

Study Start

January 1, 2015

Primary Completion

December 20, 2020

Study Completion

December 20, 2021

Last Updated

November 18, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations